Skip to main content

Table 1 Multivariate Regression for Prediction of LV MWF

From: Mid-wall fibrosis on delayed enhancement CMR - a marker for adverse left ventricular chamber remodeling independent of cardiomyopathic etiology

1A. Imaging

(Model χ2 = 26.0, p < 0.001)

  

Variable

Odds Ratio

95% Confidence Interval

P

LV Ejection Fraction (per 10% decrement)

1.46

1.03-2.10

< 0.05

LV End-Diastolic Volume (per 10 ml/m2)

1.13

1.04-1.20

< 0.05

Myocardial Mass (per 10 gm/m2)

0.95

0.85-1.00

0.29

1B. Clinical

(Model χ2 = 76.7, p < 0.001)

  

Variable

Odds Ratio

95% Confidence Interval

P

Hypertension

0.10

0.36 - 1.10

0.10

Hypercholesterolemia

0.94

0.59 - 1.78

0.94

Age (years)

0.70

0.99 - 1.00

0.70

Non-Ischemic Etiology

8.4

4.78- 14.72

< 0.001

1C. Integrated Clinical/Imaging

(Model χ2 = 91.2, p < 0.001)

  

Variable

Odds Ratio

95% Confidence Interval

P

LV Ejection Fraction (per 10% decrement)

1.22

0.84- 1.78

0.29

LV End-Diastolic Volume (10 ml/m2)

1.11

1.03 - 1.20

< 0.05

Non-Ischemic Etiology

8.22

4.75 - 14.2

< 0.001